Is the timing of BCG administration important in the immunemodulation of lung allergic response?

M. L. B. Garcia, A. Perini, T. S. Pinto, M. M. P. Acencio, M. T. Barros, O. Ibanez, M. A. Martins (Sao Paulo, Brazil)

Source: Annual Congress 2004 - Modulation of the allergic response in animal models
Session: Modulation of the allergic response in animal models
Session type: Oral Presentation
Number: 167
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. L. B. Garcia, A. Perini, T. S. Pinto, M. M. P. Acencio, M. T. Barros, O. Ibanez, M. A. Martins (Sao Paulo, Brazil). Is the timing of BCG administration important in the immunemodulation of lung allergic response?. Eur Respir J 2004; 24: Suppl. 48, 167

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IgG4 response to high occupational aeroallergen exposure: a protective mechanism against allergic and inflammatory airway disease?
Source: Eur Respir J 2002; 20: Suppl. 38, 120s
Year: 2002

Physiologic and immunologic response of the airways to LPS inhalation
Source: Annual Congress 2005 - Microorganisms: good, bad or ugly in allergic respiratory disease
Year: 2005

Modulation of inflammatory cells apoptosis induced by oral tolerance in a model of chronic allergic airway inflammation in guinea pigs
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005


In vivo blockade of CTLA-4 counteracts inhalation tolerance and leads to development of allergic airway inflammation in mice repeatedly exposed to aerosolized ovalbumin
Source: Eur Respir J 2004; 24: Suppl. 48, 6s
Year: 2004

Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007

Does a short course of oral glucocorticoids interfere with immune response in children with acute asthma?
Source: Eur Respir J 2006; 28: Suppl. 50, 709s
Year: 2006

Investigation of the very early immune response in viral induced experimental asthma exacerbation
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



The immune characteristics of inhalational tolerance induced by prolonged allergen exposure
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007


The role of interleukin-17 in asthma: a protective response?
Source: ERJ Open Res, 6 (2) 00364-2019; 10.1183/23120541.00364-2019
Year: 2020



Characterisation of type two immune responses in a murine model of allergic airway disease
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020


The effect of smoking on the response to nasal antigen challenge in patients with allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 217s
Year: 2002

Intranasal dust exposure decreases Th2 driven allergic inflammation and increases the Th17 response in mice
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019



T-cell mediated inflammation is is not required for sustained AHR that persists in mice following chronic allergen challenge
Source: Eur Respir J 2003; 22: Suppl. 45, 482s
Year: 2003

Allergen avoidance improves allergic inflammation control through regulation of the AQP5-EGFR-mucin pathway
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Young Investigator session: Perinatal antibiotic treatment affects murine microbiota, immune responses, and pathology in models of allergic asthma and hypersensitivity pneumonitis
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013

Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018


Influenza vaccination after lung transplantation: does nasal application improve immunological response?
Source: Eur Respir J 2001; 18: Suppl. 33, 179s
Year: 2001